AnyGenes

AnyGenes - The Biomarker Signalling Pathway Profiler

AnyGenes was founded in 2007 by scientists with more than 20 years of experience in molecular and cell biology and is located in Paris.

The company's main focus is on cell signalling pathways (from adipogenesis to wound healing), epigenetics and RNA expression.

AnyGenes' product portfolio includes more than 500 cell signalling pathways developed and ready for use in many species at the gene expression level and is constantly expanding.

The detection of mycoplasma in cell cultures, the analysis of biomarkers in a small number of cells, the expression analysis of LncRNA (long non-coding RNA) and specific assays for the analysis of the microbiome are among the key points of the company's product development.

AnyGenes' proprietary platform for customised services is also finding strong traction.

These include drug development, biomarker validation and mechanism of action analysis. AnyGenes' scientists use and master state-of-the-art molecular technologies and work hard for the success of each project. This quality is reflected in the consistently high satisfaction of their customers.

The goal at AnyGenes is to provide scientists with the highest level of molecular services and easy-to-use kits. AnyGenes believes that its innovative tools for analysing RNA and pathway dysfunction in many diseases, including cancer, will contribute effectively to the development of precision medicine.

Search for products by AnyGenes

AnyGenes products by Product Category

• 
  Arrays
• 
  Nucleic Acids
• 
  Other Assays & Kits
• 
  Reagents & Chemicals
• 
  All Products